NCT06251453View on ClinicalTrials.gov

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

UnknownOBSERVATIONAL
Enrollment

3,280

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

January 31, 2025

Conditions
Atrial Fibrillation
Interventions
DRUG

SGLT2 inhibitor

Dapagliflozin Empagliflzoin

Trial Locations (2)

3050

RECRUITING

Alaa Rahal, Doha

RECRUITING

Hamad medical corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY